Multimarker screening of oxidative stress in aging

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Syslová, Kamila ^a   Böhmová, Adéla ^a   Mikoška, Miloš ^a   Kuzma, Marek ^a   Pelclová, Daniela ^b   Kačer, Petr ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BODY FLUIDS; NUCLEIC ACIDS; OXIDATIVE STRESS; PHOSPHOLIPIDS; PHYSIOLOGY; PROTEINS;

3-NITROTYROSINE; ANALYTICAL METHOD; COMPLEX PROCESSES; HEALTHY PEOPLE; OXIDATIVE DAMAGE; PHYSIOLOGICAL CONCENTRATIONS; PHYSIOLOGICAL FUNCTIONS;

BIOMARKERS;

3 (2 HYDROXYPHENYL)ALANINE; 3 CHLOROTYROSINE; 3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; 8 ISOPROSTANE; ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; ESTROGEN RECEPTOR ALPHA; META TYROSINE; NUCLEIC ACID; PHOSPHOLIPID; 8-EPI-PROSTAGLANDIN F2ALPHA; GUANOSINE; PROSTAGLANDIN F2 ALPHA; PROTEIN; TYROSINE;

ADULT; AGING; ANALYTIC METHOD; BODY FLUID; CHEMICAL STRUCTURE; CONTROLLED STUDY; ELECTRONIC NOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR FLUID; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MASS SPECTROMETRY; MIDDLE AGED; NONHUMAN; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATION; OXIDATION KINETICS; OXIDATIVE STRESS; PHYSIOLOGICAL PROCESS; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; REVIEW; SCREENING TEST; SENSITIVITY ANALYSIS; YOUNG ADULT; ANALOGS AND DERIVATIVES; CHEMISTRY; DNA DAMAGE; METABOLISM;

AGING; BIOLOGICAL MARKERS; DINOPROST; DNA DAMAGE; GUANOSINE; HUMANS; OXIDATIVE STRESS; PROTEINS; TYROSINE;

EID: 84925884784     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/562860     Document Type: Review

References (124)

1. B. S. Mandavilli, J. H. Santos, and B. Van Houten, "Mitochondrial DNA repair and aging", Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 509, no. 1-2, pp. 127-151, 2002.
2. G. Block, M. Dietrich, E. P. Norkus, and L. Packer, "Oxidative stress in human's populations", in Critical Reviews of Oxidative Stress and Aging: Advances in Basic Science, Diagnostic and Interventions, R. G. Cutler and H. Rodriguez, Eds., pp. 870-880, World Scientific Publishing, Singapore, 2003.
3. F. L. Muller, M. S. Lustgarten, Y. Jang, A. Richardson, and H. Van Remmen, "Trends in oxidative aging theories", Free Radical Biology and Medicine, vol. 43, no. 4, pp. 477-503, 2007.
4. D. Harman, "Aging: a theory based on free radical and radiation chemistry", Journal of Gerontology, vol. 11, no. 3, pp. 298-300, 1956.
5. D. Harman, "The biologic clock: the mitochondria?" Journal of the American Geriatrics Society, vol. 20, no. 4, pp. 145-147, 1972.
6. E. R. Stadtman, "Role of oxidant species in aging", Current Medicinal Chemistry, vol. 11, no. 9, pp. 1105-1112, 2004.
7. H. Sies, "Introductory remarks", in Oxidative Stress, pp. 1-8, Academic Press, London, UK, 1985.
8. P. Montuschi, C. Mondino, P. Koch, G. Ciabattoni, P. J. Barnes, and G. Baviera, "Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma", Chest, vol. 132, no. 6, pp. 1876-1881, 2007.
9. K. W. Tsang, S. K. Ip, R. Leung et al., "Exhaled nitric oxide: the effects of age, gender and body size", Lung, vol. 179, no. 2, pp. 83-91, 2001.
10. P. Montuschi, "Measurement of biomarkers of oxidative stress and airway inflammation in exhaled breath condensate: methodology and potential applications in patients with COPD and healthy smokers", in Volatile Biomarkers, A. Amann and D. Smith, Eds., chapter 19, pp. 360-381, Elsevier, Boston, Mass, USA, 2013.
11. S. Asami, H. Manabe, J. Miyake et al., "Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung", Carcinogenesis, vol. 18, no. 9, pp. 1763-1766, 1997.
12. M. Malerba and P. Montuschi, "Non-invasive biomarkers of lung inflammation in smoking subjects", Current Medicinal Chemistry, vol. 19, no. 2, pp. 187-196, 2012.
13. R. J. Laumbach and H. M. Kipen, "Acute effects of motor vehicle traffic-related air pollution exposures on measures of oxidative stress in human airways", Annals of the New York Academy of Sciences, vol. 1203, pp. 107-112, 2010.
14. P. S. Green, A. J. Mendez, J. S. Jacob et al., "Neuronal expression ofmyeloperoxidase is increased in Alzheimer's disease", Journal of Neurochemistry, vol. 90, no. 3, pp. 724-733, 2004.
15. K. Hensley, M. L. Maidt, Z. Yu, H. Sang, W. R. Markesbery, and R. A. Floyd, "Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation", Journal of Neuroscience, vol. 18, no. 20, pp. 8126-8132, 1998.
16. H. Tohgi, T. Abe, K. Yamazaki, T. Murata, E. Ishizaki, and C. Isobe, "Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease", Neuroscience Letters, vol. 269, no. 1, pp. 52-54, 1999.
17. N. Ahmed, U. Ahmed, P. J. Thornalley, K. Hager, G. Fleischer, and G. Münch, "Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment", Journal of Neurochemistry, vol. 92, no. 2, pp. 255-263, 2005.
18. A. Nunomura, G. Perry, M. A. Pappolla et al., "RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease", Journal of Neuroscience, vol. 19, no. 6, pp. 1959-1964, 1999.
19. T. Abe, H. Tohgi, C. Isobe, T. Murata, and C. Sato, "Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease", Journal of Neuroscience Research, vol. 70, no. 3, pp. 447-450, 2002.
20. P. W. Pemberton, Y. Ahmad, H. Bodill et al., "Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis", BMC Research Notes, vol. 2, article 83, 2009.
21. F. Khan and A. A. Siddiqui, "Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus", Clinica Chimica Acta, vol. 370, no. 1-2, pp. 100-107, 2006.
22. H. Kaur and B. Halliwell, "Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients", FEBS Letters, vol. 350, no. 1, pp. 9-12, 1994.
23. S. Hajizadeh, J. DeGroot, J. M. TeKoppele, A. Tarkowski, and L. V. Collins, "Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis", Arthritis research & therapy, vol. 5, no. 5, pp. R234-R240, 2003.
24. L. C. Rall, R. Roubenoff, S. N. Meydani, S. N. Han, and M. Meydani, "Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) as amarker of oxidative stress in rheumatoid arthritis and aging: effect of progressive resistance training", Journal of Nutritional Biochemistry, vol. 11, no. 11-12, pp. 581-584, 2000.
25. S. L. Hazen and J. W. Heinecke, "3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima", Journal of Clinical Investigation, vol. 99, no. 9, pp. 2075-2081, 1997.
26. N. Sucu, A. Ünlü, L. Tamer et al., "3-Nitrotyrosine in atherosclerotic blood vessels", Clinical Chemistry and Laboratory Medicine, vol. 41, no. 1, pp. 23-25, 2003.
27. P. Jaruga, R. Rozalski, A. Jawien, A. Migdalski, R. Olinski, and M. Dizdaroglu, "DNA damage products (5' R) - and (5' S)-8, 5'-cyclo-2'-deoxyadenosines as potential biomarkers in human urine for atherosclerosis", Biochemistry, vol. 51, no. 9, pp. 1822-1824, 2012.
28. B. Wang, H. Zhu, H. Sun, J. Pan, Z. Yuan, and R. Yu, "Plasma 8-isoprostane concentrations in patients with agerelated cataracts", Clinical Chemistry, vol. 51, no. 8, pp. 1541-1544, 2005.
29. G. A. Molnár, V. Nemes, Z. Biró, A. Ludány, Z. Wagner, and I. Wittmann, "Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase", Free Radical Research, vol. 39, no. 12, pp. 1359-1366, 2005.
30. O. Ates, H. H. Alp, I. Kocer, O. Baykal, and I. A. Salman, "Oxidative DNA damage in patients with cataract", Acta Ophthalmologica, vol. 88, no. 8, pp. 891-895, 2010.
31. R. Rodrigo, H. Prat, W. Passalacqua, J. Araya, and J. P. Bächler, "Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension", Clinical Science, vol. 114, no. 9-10, pp. 625-634, 2008.
32. A. Hozawa, S. Ebihara, K. Ohmori et al., "Increased plasma 8-isoprostane levels in hypertensive subjects: the Tsurugaya project", Hypertension Research, vol. 27, no. 8, pp. 557-561, 2004.
33. R. Bowers, C. Cool, R. C. Murphy et al., "Oxidative stress in severe pulmonary hypertension", American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 6, pp. 764-769, 2004.
34. P. Subash, P. Gurumurthy, A. Sarasabharathi, and K. M. Cherian, "Urinary 8-OHdG: a marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population", Indian Journal of Clinical Biochemistry, vol. 25, no. 2, pp. 127-132, 2010.
35. K. H. Baek, K. W. Oh, W. Y. Lee et al., "Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures", Calcified tissue international, vol. 87, no. 3, pp. 226-235, 2010.
36. E. Nobécourt, S. Jacqueminet, B. Hansel et al., "Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia", Diabetologia, vol. 48, no. 3, pp. 529-538, 2005.
37. N. Moussavi, G. Renier, A. Roussin, J.-C. Mamputu, J. Buithieu, and O. Serri, "Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes", Diabetes, Obesity and Metabolism, vol. 6, no. 1, pp. 69-77, 2004.
38. S. Nakanishi, G. Suzuki, Y. Kusunoki, K. Yamane, G. Egusa, and N. Kohno, "Increasing of oxidative stress from mitochondria", Diabetes/Metabolism Research and Reviews, vol. 20, no. 5, pp. 399-404, 2004.
39. G. A. Molnár, Z. Wagner, L. Markó et al., "Urinary orthotyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production", Kidney International, vol. 68, no. 5, pp. 2281-2287, 2005.
40. J. D. Morrow and L. J. Roberts II, "The isoprostanes: current knowledge and directions for future research", Biochemical Pharmacology, vol. 51, no. 1, pp. 1-9, 1996.
41. D. J. Berezan, K. M. J. Dunn, J. R. Falck, and S. T. Davidge, "Aging increases cytochrome P450 4A modulation of α1-adrenergic vasoconstriction in mesenteric arteries", Journal of Cardiovascular Pharmacology, vol. 51, no. 3, pp. 327-330, 2008.
42. I. Mohiuddin, H. Chai, P. H. Lin, A. B. Lumsden, Q. Yao, and C. Chen, "Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system", Journal of Surgical Research, vol. 133, no. 2, pp. 143-149, 2006.
43. J. D. Morrow, T. A. Minton, and L. J. Roberts II, "The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist", Prostaglandins, vol. 44, no. 2, pp. 155-163, 1992.
44. J. L. Elmhurst, P.-A. Betti, and P. K. Rangachari, "Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors", Journal of Pharmacology and Experimental Therapeutics, vol. 282, no. 3, pp. 1198-1205, 1997.
45. B. M. Kromer and J. R. Tippins, "Coronary artery constriction by the isoprostane 8-epi prostaglandin F (2α)", British Journal of Pharmacology, vol. 119, no. 6, pp. 1276-1280, 1996.
46. V. Tesar and T. Zima, "Isoprostany-nove markery a mediatory oxidacniho stresu", Remedia, vol. 9, no. 5, pp. 308-316, 1999.
47. P. Montuschi, J. V. Collins, G. Ciabattoni et al., "Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers", American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3, pp. 1175-1177, 2000.
48. K. Kostikas, A. Koutsokera, S. Papiris, K. I. Gourgoulianis, and S. Loukides, "Exhaled breath condensate in patients with asthma: implications for application in clinical practice", Clinical and Experimental Allergy, vol. 38, no. 4, pp. 557-565, 2008.
49. P. Montuschi and P. J. Barnes, "Isoprostanes and asthma", Drug Discovery Today: Therapeutic Strategies, vol. 3, no. 3, pp. 287-292, 2006.
50. E. K. Shanle and W. Xu, "Selectively targeting estrogen receptors for cancer treatment", Advanced Drug Delivery Reviews, vol. 62, no. 13, pp. 1265-1276, 2010.
51. A. Gupta, P. Saha, C. Descôteaux, V. Leblanc, É. Asselin, and G. Bérubé, "Design, synthesis and biological evaluation of estradiol-chlorambucil hybrids as anticancer agents", Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 5, pp. 1614-1618, 2010.
52. C. Van Themsche, S. Parent, V. Leblanc et al., "VP-128, a novel oestradiol-platinum (II) hybrid with selective antitumour activity towards hormone-dependent breast cancer cells in vivo", Endocrine-Related Cancer, vol. 16, no. 4, pp. 1185-1195, 2009.
53. C. Descôteaux, K. Brasseur, V. Leblanc, S. Parent, É. Asselin, and G. Bérubé, "SAR study of tyrosine-chlorambucil hybrid regioisomers; Synthesis and biological evaluation against breast cancer cell lines", Amino Acids, vol. 43, no. 2, pp. 923-935, 2012.
54. J. E. Harrison and J. Schultz, "Studies on the chlorinating activity of myeloperoxidase", Journal of Biological Chemistry, vol. 251, no. 5, pp. 1371-1374, 1976.
55. S. J. Klebanoff, "Myeloperoxidase: friend and foe", Journal of Leukocyte Biology, vol. 77, no. 5, pp. 598-625, 2005.
56. A. Kontush and M. J. Chapman, "Functionally defective highdensity lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis", Pharmacological Reviews, vol. 58, no. 3, pp. 342-374, 2006.
57. J. F. Oramand J. W. Heinecke, "ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease", Physiological Reviews, vol. 85, no. 4, pp. 1343-1372, 2005.
58. M. Passarelli, C. Tang, T. O. McDonald et al., "Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal fromcells", Diabetes, vol. 54, no. 7, pp. 2198-2205, 2005.
59. M. L. Fitzgerald, A. L. Morris, A. Chroni, A. J. Mendez, V. I. Zannis, and M. W. Freeman, "ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux", Journal of Lipid Research, vol. 45, no. 2, pp. 287-294, 2004.
60. N. Wang, D. L. Silver, P. Costet, and A. R. Tall, "Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1", Journal of Biological Chemistry, vol. 275, no. 42, pp. 33053-33058, 2000.
61. H. H. Hassan, M. Denis, D.-Y. D. Lee et al., "Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis", Journal of Lipid Research, vol. 48, no. 11, pp. 2428-2442, 2007.
62. A. M. Vaughan, C. Tang, and J. F. Oram, "ABCA1mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation", Journal of Lipid Research, vol. 50, no. 2, pp. 285-292, 2009.
63. C. Vedhachalam, P. T. Duong, M. Nickel et al., "Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles", Journal of Biological Chemistry, vol. 282, no. 34, pp. 25123-25130, 2007.
64. C. Vedhachalam, A. B. Ghering, W. S. Davidson, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips, "ABCA1-induced cell surface binding sites for ApoA-I", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 7, pp. 1603-1609, 2007.
65. B. Shao, C. Tang, J. W. Heinecke, and J. F. Oram, "Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export", Journal of Lipid Research, vol. 51, no. 7, pp. 1849-1858, 2010.
66. H. Mu, X. Wang, P. H. Lin, Q. Yao, and C. Chen, "Chlorotyrosine promotes human aortic smooth muscle cell migration through increasing superoxide anion production and ERK1/2 activation", Atherosclerosis, vol. 201, no. 1, pp. 67-75, 2008.
67. T. E. Creighton, Proteins: Structures and Molecular Properties, Freeman W. H. and Company, New York, NY, USA, 2nd edition, 1993.
68. J. M. Souza, I. Choi, Q. Chen et al., "Proteolytic degradation of tyrosine nitrated proteins", Archives of Biochemistry and Biophysics, vol. 380, no. 2, pp. 360-366, 2000.
69. S. N. Savvides, M. Scheiwein, C. C. Böhme et al., "Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite", Journal of Biological Chemistry, vol. 277, no. 4, pp. 2779-2784, 2002.
70. J. M. Souza, E. Daikhin, M. Yudkoff, C. S. Raman, and H. Ischiropoulos, "Factors determining the selectivity of protein tyrosine nitration", Archives of Biochemistry and Biophysics, vol. 371, no. 2, pp. 169-178, 1999.
71. J. M. Souza, G. Peluffo, and R. Radi, "Protein tyrosine nitrationfunctional alteration or just a biomarker?" Free Radical Biology and Medicine, vol. 45, no. 4, pp. 357-366, 2008.
72. L. A. Macmillan-Crow, J. P. Crow, J. D. Kerby, J. S. Beckman, and J. A. Thompson, "Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts", Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 21, pp. 11853-11858, 1996.
73. M. Zou, C. Martin, and V. Ullrich, "Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite", Biological Chemistry, vol. 378, no. 7, pp. 707-713, 1997.
74. A. M. Cassina, R. Hodara, J. M. Souza et al., "Cytochrome c nitration by peroxynitrite", Journal of Biological Chemistry, vol. 275, no. 28, pp. 21409-21415, 2000.
75. C. Batthyány, J. M. Souza, R. Durán, A. Cassina, C. Cerveñansky, and R. Radi, "Time course and site (s) of cytochrome c tyrosine nitration by peroxynitrite", Biochemistry, vol. 44, no. 22, pp. 8038-8046, 2005.
76. C. Vadseth, J. M. Souza, L. Thomson et al., "Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species", Journal of Biological Chemistry, vol. 279, no. 10, pp. 8820-8826, 2004.
77. Z. Balafanova, R. Bolli, J. Zhang et al., "Nitric oxide (NO) induces nitration of protein kinase Cε (PKCε), facilitating PKCε translocation via enhanced PKCε-RACK2 interactions. A novel mechanism of no-triggered activation of PKCε", Journal of Biological Chemistry, vol. 277, no. 17, pp. 15021-15027, 2002.
78. J. M. Souza, L. Castro, A. M. Cassina, C. Batthyány, and R. Radi, "Nitrocytochrome c: synthesis, Purification, and Functional Studies", Methods in Enzymology, vol. 441, pp. 197-215, 2008.
79. D. Francescutti, J. Baldwin, L. Lee, and B. Mutus, "Peroxynitrite modification of glutathione reductase: modeling studies and kinetic evidence suggest the modification of tyrosines at the glutathione disulfide binding site", Protein Engineering, vol. 9, no. 2, pp. 189-194, 1996.
80. M. Pehar, M. R. Vargas, K. M. Robinson et al., "Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons", Free Radical Biology and Medicine, vol. 41, no. 11, pp. 1632-1644, 2006.
81. B. Blanchard-Fillion, J. M. Souza, T. Friel et al., "Nitration and inactivation of tyrosine hydroxylase by peroxynitrite", Journal of Biological Chemistry, vol. 276, no. 49, pp. 46017-46023, 2001.
82. L. T. Knapp, B. I. Kanterewicz, E. L. Hayes, and E. Klann, "Peroxynitrite-induced tyrosine nitration and inhibition of protein kinase C", Biochemical and Biophysical Research Communications, vol. 286, no. 4, pp. 764-770, 2001.
83. M. Skvarilová, A. Bulava, D. Stejskal, S. Adamovská, and J. Bartek, "Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome", Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, vol. 149, no. 1, pp. 83-87, 2005.
84. H. Alagozlua, A. Gorgulb, A. Bilgihanc, C. Tuncerb, and S. Unalb, "Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis", Clinics and Research in Hepatology and Gastroenterology, vol. 37, pp. 80-85, 2013.
85. H. Kasai, K. Kawai, and Y. Li, "Analysis of 8-OH-dG and 8-OHGua as biomarkers of oxidative stress", Genes and Environment, vol. 30, no. 2, pp. 33-40, 2008.
86. B. Malayappan, T. J. Garrett, M. Segal, and C. Leeuwenburgh, "Urinary analysis of 8-oxoguanine, 8-oxoguanosine, fapyguanine and 8-oxo-2'-deoxyguanosine by high-performance liquid chromatography-electrospray tandem mass spectrometry as a measure of oxidative stress", Journal of Chromatography A, vol. 1167, no. 1, pp. 54-62, 2007.
87. H. Hayakawa and M. Sekiguchi, "Human polynucleotide phosphorylase protein in response to oxidative stress", Biochemistry, vol. 45, no. 21, pp. 6749-6755, 2006.
88. X. Shan, H. Tashiro, and C.-L. G. Lin, "The identification and characterization of oxidized RNAs in Alzheimer's disease", Journal of Neuroscience, vol. 23, no. 12, pp. 4913-4921, 2003.
89. X. Shan, Y. Chang, and C.-L. G. Lin, "MessengerRNAoxidation is an early event preceding cell death and causes reduced protein expression", FASEB Journal, vol. 21, no. 11, pp. 2753-2764, 2007.
90. S. Choi, H.-H. Choi, S.-H. Lee et al., "Anti-inflammatory effects of 8-hydroxy-2'-deoxyguanosine on lipopolysaccharideinduced inflammation via Rac suppression in Balb/c mice", Free Radical Biology and Medicine, vol. 43, no. 12, pp. 1594-1603, 2007.
91. M. Irie, K. Tamae, N. Iwamoto-Tanaka, and H. Kasai, "Occupational and lifestyle factors and urinary 8-hydroxydeoxyguanosine", Cancer Science, vol. 96, no. 9, pp. 600-606, 2005.
92. P. Montuschi, F. Varone, and S. Valente, "Methodological aspects of exhaled prostanoids measurements", European Respiratory Journal, vol. 22, no. 45, article 18s, 2003.
93. P. Montuschi, E. Ragazzoni, S. Valente et al., "Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate", Inflammation Research, vol. 52, no. 12, pp. 502-507, 2003.
94. E. Baraldi, L. Ghiro, V. Piovan et al., "Increased exhaled 8-isoprostane in childhood asthma", Chest, vol. 124, no. 1, pp. 25-31, 2003.
95. C. T. Carpenter, P. V. Price, and B. W. Christman, "Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS", Chest, vol. 114, no. 6, pp. 1653-1659, 1998.
96. N. Ohashi and M. Yoshikawa, "Rapid and sensitive quantification of 8-isoprostaglandin F (2α) in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry", Journal of Chromatography B: Biomedical Sciences and Applications, vol. 746, no. 1, pp. 17-24, 2000.
97. K. Syslova, P. Kacer, M. Kuzma et al., "Determination of 8-iso-prostaglandin F (2 alpha) in exhaled breath condensate using combination of immunoseparation and LC-ESI-MS/MS", Journal of Chromatography B, vol. 867, no. 1, pp. 8-14, 2008.
98. S. Pennathur, V. Jackson-Lewis, S. Przedborski, and J. W. Heinecke, "Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o, o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease", Journal of Biological Chemistry, vol. 274, no. 49, pp. 34621-34628, 1999.
99. C. Leeuwenburgh, J. E. Rasmussen, F. F. Hsu, D. M. Mueller, S. Pennathur, and J. W. Heinecke, "Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques", Journal of Biological Chemistry, vol. 272, no. 6, pp. 3520-3526, 1997.
100. C. Matayatsuk, A. Poljak, S. Bustamante et al., "Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in β-thalassemia", Redox Report, vol. 12, no. 5, pp. 219-228, 2007.
101. H. Orhan, N. P. E. Vermeulen, C. Tump, H. Zappey, and J. H. N. Meerman, "Simultaneous determination of tyrosine, phenylalanine and deoxyguanosine oxidation products by liquid chromatography-tandem mass spectrometry as non-invasive biomarkers for oxidative damage", Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 799, no. 2, pp. 245-254, 2004.
102. K. Syslová, P. Kačer, M. Kuzma et al., "LC-ESI-MS/MS method for oxidative stressmultimarker screening in the exhaled breath condensate of asbestosis/silicosis patients", Journal of Breath Research, vol. 4, no. 1, Article ID 017104, 2010.
103. M.-L. Cheng, C.-M. Chen, P.-W. Gu, H.-Y. Ho, and D. T.-Y. Chiu, "Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction", Clinical Biochemistry, vol. 41, no. 7-8, pp. 554-560, 2008.
104. S. Sentürker, B. Karahalil, M. Inal, H. Yilmaz, G. Gedikoglu, and M. Dizdaroglu, "Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia", FEBS Letters, vol. 416, no. 3, pp. 286-290, 1997.
105. M. Barreto, M. P. Villa, C. Olita, S. Martella, G. Ciabattoni, and P. Montuschi, "8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents", Chest, vol. 135, no. 1, pp. 66-73, 2009.
106. V. Lucidi, G. Ciabattoni, S. Bella, P. J. Barnes, and P. Montuschi, "Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosisstar, open", Free Radical Biology and Medicine, vol. 45, no. 6, pp. 913-919, 2008.
107. A. Gumieniczek, B. Owczarek, and B. Pawlikowska, "Oxidative/nitrosative stress and protein damages in aqueous humor of hyperglycemic rabbits: effects of two oral antidiabetics, pioglitazone and repaglinide", Experimental Diabetes Research, vol. 2012, Article ID 653678, 6 pages, 2012.
108. F. Di Domenico, R. Coccia, D. A. Butterfield, and M. Perluigi, "Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits", Biochimica et Biophysica Acta: Proteins and Proteomics, vol. 1814, no. 12, pp. 1785-1795, 2011.
109. R. Sultana and D. A. Butterfield, "Identification of the oxidative stress proteome in the brain", Free Radical Biology and Medicine, vol. 50, no. 4, pp. 487-494, 2011.
110. D. A. Butterfield, M. Perluigi, and R. Sultana, "Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics", European Journal of Pharmacology, vol. 545, no. 1, pp. 39-50, 2006.
111. P. Montuschi, N. Mores, A. Trové, C. Mondino, and P. J. Barnes, "The electronic nose in respiratory medicine", Respiration, vol. 85, no. 1, pp. 72-84, 2013.
112. M. Bofan, N. Mores, M. Baron et al., "Within-day and betweenday repeatability of measurements with an electronic nose in patients with COPD", Journal of Breath Research, vol. 7, no. 1, Article ID 017103, 2013.
113. G. De Laurentiis, D. Paris, D. Melck et al., "Separating smokingrelated diseases using NMR-based metabolomics of exhaled breath condensate", Journal of Proteome Research, vol. 12, no. 3, pp. 1502-1511, 2013.
114. A. Motta, D. Paris, D. Melck et al., "Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects", European Respiratory Journal, vol. 39, no. 2, pp. 498-500, 2012.
115. P. Montuschi, D. Paris, D. Melck et al., "NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis", Thorax, vol. 67, no. 3, pp. 222-228, 2012.
116. C. E. Wheelock, V. M. Goss, D. Balgoma et al., "Application of 'omics technologies to biomarker discovery in inflammatory lung diseases", European Respiratory Journal, vol. 42, no. 3, pp. 802-825, 2013.
117. A.-S. Söderling, H. Ryberg, A. Gabrielsson et al., "A derivatization assay using gaschromatography/negative chemical ionization tandem mass spectrometry to quantify 3-nitrotyrosine in human plasma", Journal of Mass Spectrometry, vol. 38, no. 11, pp. 1187-1196, 2003.
118. E. Schwedhelm, D. Tsikas, F.-M. Gutzki, and J. C. Frölich, "Gas chromatographic-tandem mass spectrometric quantification of free 3-nitrotyrosine in human plasma at the basal state", Analytical Biochemistry, vol. 276, no. 2, pp. 195-203, 1999.
119. D. Tsikas, E. Schwedhelm, F. K. Stutzer et al., "Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry", Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 784, no. 1, pp. 77-90, 2003.
120. H. Jiang and M. Balazy, "Detection of 3-nitrotyrosine in human platelets exposed to peroxynitrite by a new gas chromatography/mass spectrometry assay", Nitric Oxide: Biology and Chemistry, vol. 2, no. 5, pp. 350-359, 1998.
121. J. Pietzsch, R. Bergmann, and S. Kopprasch, "Analysis of nonprotein amino acids as specific markers of low density lipoprotein apolipoprotein B-100 oxidation in human atherosclerotic lesions: the use of N (O)-ethoxycarbonyl trifluoroethyl ester derivatives and GC-MS", Spectroscopy, vol. 18, no. 2, pp. 177-183, 2004.
122. K. D. Jacob, N. Noren Hooten, A. R. Trzeciak, and M. K. Evans, "Markers of oxidant stress that are clinically relevant in aging and age-related disease", Mechanisms of Ageing and Development, vol. 134, no. 3-4, pp. 139-157, 2013.
123. A. Siomek, D. Gackowski, R. Rozalski et al., "Higher leukocyte 8-oxo-7, 8-dihydro-2'-deoxyguanosine and lower plasma ascorbate in aging humans?" Antioxidants and Redox Signaling, vol. 9, no. 1, pp. 143-150, 2007.
124. T. J. Montine, E. R. Peskind, J. F. Quinn, A. M. Wilson, K. S. Montine, and D. Galasko, "Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers", Neuro Molecular Medicine, vol. 13, no. 1, pp. 37-43, 2011.